Old names:
Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
RUTHERFORD DONALD W | 0001257140 | Apr-01-2005 | officer: Chief Financial Officer |
MEDINA CARMEN | 0001322430 | Feb-21-2005 | director |
Crow Kevin | 0001298442 | Aug-11-2004 | director |
Crow Michael | 0001299979 | Aug-11-2004 | 10 percent owner |
LEVINE JACK | 0001124852 | Jul-30-2004 | director |
WILSON JOHN C | 0001166394 | Jul-30-2004 | officer: Chief Financial Ofiicer |
Wilkinson Eric | 0001298443 | Jul-30-2004 | director |
Ahlin Michael | 0001298444 | Jul-30-2004 | director, 10 percent owner, officer: Vice President |
Rosenfeld Mark | 0001298445 | Jul-30-2004 | director, 10 percent owner, officer: Vice President |
Yakatan Stan | 0001298446 | Jul-30-2004 | director, officer: President & CEO |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Grant Life Sciences, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
REVOKED | Document | Acc-no: 9999999997-12-011637 (34 Act) Size: KB | Sep-21-2011 | 12961572 |
SC 13D | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001361106-08-000295 (34 Act) Size: KB |
Sep-09-2008 | 081062965 |
8-K | Document | Current report filing Acc-no: 0001361106-08-000163 (34 Act) Size: KB |
Jun-06-2008 | 08886113 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001361106-08-000133 (34 Act) Size: KB |
May-20-2008 | 08848333 |
NT 10-Q | Document | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001361106-08-000118 (34 Act) Size: KB |
May-14-2008 | 08829886 |
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001361106-08-000104 (33 Act) Size: KB |
May-06-2008 | 08807359 |
8-K | Document | Current report filing Acc-no: 0001144204-08-015336 (34 Act) Size: KB |
Mar-14-2008 | 08689281 |
10KSB | Document | Acc-no: 0001144204-08-013782 (34 Act) Size: KB | Mar-06-2008 | 08671494 |
424B3 | Document | Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001144204-08-005457 (33 Act) Size: KB |
Jan-31-2008 | 08565387 |
EFFECT | Document | Acc-no: 9999999995-08-000329 (33 Act) Size: KB | Jan-29-2008 | 08559621 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001144204-08-004440 ( Act) Size: KB |
Jan-28-2008 | |
SB-2/A | Document | Acc-no: 0001144204-08-003864 (33 Act) Size: KB | Jan-24-2008 | 08548460 |
UPLOAD | Document | Acc-no: 0000000000-08-002020 ( Act) Size: KB | Jan-11-2008 | |
SB-2 | Document | Acc-no: 0001144204-07-069398 (33 Act) Size: KB | Dec-27-2007 | 071329783 |
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001144204-07-067141 (33 Act) Size: KB |
Dec-12-2007 | 071301975 |
8-K | Document | Current report filing Acc-no: 0001144204-07-065070 (34 Act) Size: KB |
Nov-30-2007 | 071276697 |
8-K | Document | Current report filing Acc-no: 0001144204-07-062497 (34 Act) Size: KB |
Nov-16-2007 | 071252315 |
10QSB | Document | Acc-no: 0001144204-07-056816 (34 Act) Size: KB | Oct-29-2007 | 071196569 |
10QSB | Document | Acc-no: 0001144204-07-042578 (34 Act) Size: KB | Aug-13-2007 | 071049979 |
8-K | Document | Current report filing Acc-no: 0001144204-07-033195 (34 Act) Size: KB |
Jun-22-2007 | 07936336 |
Recent 20 filings. View all Grant Life Sciences, Inc. filings
young lad who new his job ansered questions and new what was best for me.
Thanks I look forward to using the product to improve my skin tone
Very good communication and delivery made within the timeframe I was advised of
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by